Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,510.8
-4.5 (-0.18%)

 

  • STI Straits Times Index
    2,510.8
    -4.5 (-0.18%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,473.2
    15.8 (1.08%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    22,961.5
    -171.3 (-0.74%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,852.4
    6.1 (0.22%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,877.9
    -38.4 (-0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,753.6
    37.4 (0.79%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2,816.8M
  • Value: 4,142.6M
  • Rise: 214
  • Fall: 121
  • Unch: 473

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Mapletree Log Tr2.050+0.130
ComfortDelGro1.440-0.060
SPH1.280-0.180
Rex Intl0.155+0.015
Sembcorp Ind1.360-0.150
SATS2.660-0.160
Broadway Ind^0.116+0.018
Singtel2.490-0.020
CapitaMall Trust2.030+0.100
Oceanus^0.005-

World Indices

World Indices
Name Last Change
Nasdaq 9,369.0 -43.4
HSI 22,961.5 -171.3
HSCEI 9,561.0 +9.5
Jakarta 4,753.6 +37.4
Nikkei 225 21,877.9 -38.4
SSE Comp 2,852.4 +6.1
Shanghai A 2,989.9 +6.6
Shanghai B 200.2 -5.3
KOSPI 2,029.6 +1.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ACLARIS THERAPEUTICS INC ACLARIS THERAPEUTICS
Updated on 28 May 2020 (End of trading day)
Last (USD): 1.340 Change: - High: 1.370 Remarks: -
Change (%): - Low: 1.320
Open 1.360 Yesterday's Close 1.34
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 179,860 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -3.85403 Trailing EPS (USD) e -3.32905 NAV (USD) b 1.3895
PE a - Trailing PE f - Price / NAV b 0.9644
Dividend (USD) d - Cash In Hand (USD) g 1.2896 Issued & Paid-up Shares c 41,866,300
Dividend Yield (%) d - Price / Cash In Hand g 1.039 Treasury Shares h -
Beta - 75 Daysi 0.667 R-Squared - 75 Days(%)i 15.22 Market Cap (M) 56.101
Beta - 500 Daysi 0.423 R-Squared - 500 Days (%)i 1.43 Enterprise Value (M) -8.303
Piotroski F Score 1 Exchange Code ACRS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 121.55 Free Float (%) 75.4
Sector & Industry Health Technology - Pharmaceuticals: Other
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 08 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 06 Oct 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ACLARIS THERAPEUTICS INC NASDAQ 56.101 - - 0.9644 -
Industry Pharmaceuticals: Other NASDAQ 1,264.393 - - 4.7732 -
Local Peer HORIZON THERAPEUTICS PLC NASDAQ 9,300.427 16.231 15.702 4.2500 -
Local Peer ARGENX SE SPON ADR EACH REP 1 ORD SHS NASDAQ 9,051.860 - - 7.6746 -
Local Peer ICON PLC NASDAQ 8,695.982 23.252 23.043 5.7443 -
Local Peer JAZZ PHARMACEUTICALS PLC NASDAQ 6,572.698 12.558 23.446 2.3403 -
Local Peer MYOKARDIA INC NASDAQ 5,279.738 - - 15.1238 -
Local Peer UNITED THERAPEUTICS CORP NASDAQ 5,061.414 - 9.590 1.7166 -
Local Peer GW PHARMACEUTICALS ADS EA REPR 12 ORD GBP0.00 NASDAQ 3,899.259 - - 5.3706 -
Local Peer AXSOME THERAPEUTICS INC NASDAQ 2,837.048 - - 18.1680 -
Local Peer AMARIN CORP ADR EACH REP 1 ORD GBP0.50 NASDAQ 2,632.897 - 1,376.600 - -
Local Peer INTERCEPT PHARMACEUTICALS INC NASDAQ 2,395.866 - - -69.0067 -
Local Peer SAGE THERAPEUTICS INC NASDAQ 1,940.687 - - 2.2853 -
Local Peer PACIRA BIOSCIENCES INC NASDAQ 1,874.797 - - 5.0123 -
Other Local Peers MADRIGAL PHARMACEUTICALS INC (NASDAQ), REVOLUTION MEDICINES INC (NASDAQ), CORCEPT THERAPEUTICS INC (NASDAQ), ZOGENIX INC (NASDAQ), THERAVANCE BIOPHARMA INC (NASDAQ), IRONWOOD PHARMACEUTICALS INC (NASDAQ), INNOVIVA INC (NASDAQ), PORTOLA PHARMACEUTICALS INC (NASDAQ), SUPERNUS PHARMACEUTICALS INC (NASDAQ), REVANCE THERAPEUTICS INC (NASDAQ), ENDO INTERNATIONAL PLC (NASDAQ), AMPHASTAR PHARMACEUTICALS INC (NASDAQ), COLLEGIUM PHARMACEUTICAL INC (NASDAQ), EAGLE PHARMACEUTICALS INC (NASDAQ), AERIE PHARMACEUTICALS INC (NASDAQ), ASSEMBLY BIOSCIENCES INC (NASDAQ), ANIKA THERAPEUTICS INC (NASDAQ), BIODELIVERY SCIENCES INTERNATIONAL (NASDAQ), CATALYST PHARMACEUTICALS INC (NASDAQ), ALBIREO PHARMA INC (NASDAQ), ANI PHARMACEUTICALS INC (NASDAQ), INTERSECT ENT INC (NASDAQ), MEI PHARMA INC (NASDAQ), AGILE THERAPEUTICS INC (NASDAQ), MARINUS PHARMACEUTICALS INC (NASDAQ), CERECOR INC (NASDAQ), ZYNERBA PHARMACEUTICALS INC (NASDAQ), ACELRX PHARMACEUTICALS INC (NASDAQ), GALMED PHARMACEUTICALS LTD (NASDAQ), QUALIGEN THERAPEUTICS INC (NASDAQ), ADAMAS PHARMACEUTICALS INC (NASDAQ), ORAMED PHARMACEUTICALS INC (NASDAQ), SCYNEXIS INC (NASDAQ), CTI BIOPHARMA CORP (NASDAQ), HAPPINESS BIOTECH GROUP LTD (NASDAQ), VERONA PHARMA SPON ADR EACH REP 8 ORD SHS (NASDAQ), EVOKE PHARMA INC (NASDAQ), ACASTI PHARMA INC (NASDAQ), CASSAVA SCIENCES INC (NASDAQ), CUMBERLAND PHARMACEUTICALS INC (NASDAQ), NATURAL ALTERNATIVES INTERNATIONAL (NASDAQ), LIPOCINE INC (NASDAQ), PLX PHARMA INC (NASDAQ), TONIX PHARMACEUTICALS HLDG CORP (NASDAQ), NEOS THERAPEUTICS INC (NASDAQ), EYEGATE PHARMACEUTICALS INC (NASDAQ), BIOLINE RX LTD SPON ADS EACH REPR 15 ORD SHS (NASDAQ), VIVUS INC (NASDAQ), RITTER PHARMACEUTICALS INC (NASDAQ), REGULUS THERAPEUTICS INC (NASDAQ), INTEC PHARMA LTD (NASDAQ), HEPION PHARMACEUTICALS INC (NASDAQ), TETRAPHASE PHARMACEUTICALS INC (NASDAQ), SONOMA PHARMACEUTICALS INC (NASDAQ)
Global Peer CATALENT INC NYSE 11,911.656 90.240 114.756 5.4448 -
Global Peer FOSUN PHARMA HKEx 63,047.365 16.739 16.739 1.7707 1.732
Global Peer PERRIGO COMPANY PLC NYSE 7,501.304 51.344 39.774 1.2964 1.488
Global Peer BAUSCH HEALTH COMPANIES INC NYSE 6,590.828 - - 9.1667 -
Global Peer Kalbe Farma Tbk. IDX 66,325,188.875 26.458 25.698 4.0350 -
Global Peer LIVZON PHARMA HKEx 29,145.716 19.728 19.823 2.2972 4.028
Global Peer BELLRING BRANDS INC NYSE 2,749.008 22.331 35.609 -1.4754 -
Global Peer PRESTIGE CONSUMER HEALTHCARE INC NYSE 2,163.193 15.204 15.204 1.8474 -
Global Peer LUYE PHARMA HKEx 14,302.810 8.589 8.589 1.3862 2.844
Global Peer HEC PHARM HKEx 12,002.864 5.517 5.517 2.4340 5.374
Other Global Peers TONG REN TANG (HKEx), BLACKMORES LTD (ASX), SIHUAN PHARM (HKEx), MEGA (SET), CLINUVEL PHARMACEUTICALS LTD (ASX), FUDANZHANGJIANG (HKEx), Tianjin ZX USD (SGX), OPTHEA LIMITED (ASX), HUA HAN HEALTH (HKEx), CONSUN PHARMA (HKEx), SHANDONG XINHUA (HKEx), MALLINCKRODT PLC (NYSE), Indofarma (Persero) Tbk. (IDX), GOLDEN THROAT (HKEx), JILIN CHANGLONG (HKEx), C HEALTH GP (HKEx), OCI INTL (HKEx), DOD (SET), YSPSAH (Bursa), LONGRUN TEA (HKEx), ALTHEA GROUP HOLDINGS LTD (ASX), TIANDA PHARMA (HKEx), ISORAY INC (NYSE American), AMPIO PHARMACEUTICALS INC (NYSE American), EAGLE HEALTH HOLDINGS LTD (ASX), LANSEN PHARMA (HKEx), BOTANIX PHARMACEUTICALS LTD (ASX), IDT AUSTRALIA LIMITED (ASX), ANTISENSE THERAPEUTICS (ASX), VITA LIFE SCIENCES LIMITED (ASX), PHARMAUST LIMITED (ASX), Pyridam Farma Tbk (IDX), CRONOS AUSTRALIA LIMITED (ASX), CANNPAL ANIMAL THERAPEUTICS LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.110
+8.94 %
10 Days -+0.050
+3.88 %
20 Days -+0.100
+8.06 %
Medium Term Return 3 Months -+0.200
+17.54 %
6 Months --0.300
-18.29 %
1 Year --3.340
-71.37 %
Long Term Return 2 Years --16.920
-92.66 %
3 Years --22.270
-94.32 %
Annualised Return Annualised --
-61.57 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.700 - 5.370 Change From 1 Year Low +0.640 % Change From 1 Year Low (%) +91.43
Change From 1 Year High -4.030 % Change From 1 Year High (%) -75.05
2 Years Range 0.700 - 21.969 Change From 2 Years Low +0.640 % Change From 2 Years Low (%) +91.43
Change From 2 Years High -20.629 % Change From 2 Years High (%) -93.90
5 Years Range 0.700 - 33.880 Change From 5 Years Low +0.640 % Change From 5 Years Low (%) +91.43
Change From 5 Years High -32.540 % Change From 5 Years High (%) -96.04
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through Therapeutics and Contract Research segments. The Therapeutics segment focuses in identifying, developing, and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Malvern, PA.

Historical Price Data

Date Open High Low Close Volume VWAP
28 May 2020 1.360 1.370 1.320 1.340 179,860 -
27 May 2020 1.350 1.380 1.300 1.340 151,663 -
26 May 2020 1.270 1.340 1.260 1.320 202,751 -
22 May 2020 1.240 1.280 1.200 1.230 149,457 -
21 May 2020 1.290 1.320 1.220 1.240 174,662 -
20 May 2020 1.280 1.340 1.250 1.280 236,700 -
19 May 2020 1.290 1.340 1.260 1.280 344,353 -
18 May 2020 1.320 1.360 1.270 1.300 215,592 -
15 May 2020 1.310 1.420 1.240 1.290 166,635 -
14 May 2020 1.270 1.300 1.160 1.300 173,423 -
13 May 2020 1.390 1.390 1.190 1.310 218,061 -
12 May 2020 1.470 1.500 1.380 1.390 204,961 -
11 May 2020 1.430 1.490 1.350 1.440 279,086 -
08 May 2020 1.390 1.430 1.340 1.420 246,822 -
07 May 2020 1.310 1.370 1.250 1.370 157,402 -
06 May 2020 1.310 1.370 1.239 1.260 113,568 -
05 May 2020 1.270 1.300 1.255 1.300 135,235 -
04 May 2020 1.240 1.270 1.100 1.250 248,796 -
01 May 2020 1.300 1.300 1.210 1.240 185,342 -
30 Apr 2020 1.370 1.400 1.240 1.330 259,233 -
29 Apr 2020 1.270 1.400 1.260 1.380 334,924 -
28 Apr 2020 1.240 1.290 1.210 1.240 217,794 -
Summary
Current 2 Weeks
(14 May 2020 to 28 May 2020)
1.270 1.420 1.160 1.340 1,995,096 -
Previous 2 Weeks
(30 Apr 2020 to 13 May 2020)
1.370 1.420 1.160 1.310 2,048,506 -
4 Weeks from
(01 Apr 2020 to 29 Apr 2020)
1.030 1.420 0.960 1.380 4,868,509 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.